Enzo Biochem Stock Probability of Future Stock Price Finishing Under 1.06

ENZ Stock  USD 0.73  0.02  2.82%   
Enzo Biochem's future price is the expected price of Enzo Biochem instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Enzo Biochem performance during a given time horizon utilizing its historical volatility. Check out Enzo Biochem Backtesting, Enzo Biochem Valuation, Enzo Biochem Correlation, Enzo Biochem Hype Analysis, Enzo Biochem Volatility, Enzo Biochem History as well as Enzo Biochem Performance.
For more information on how to buy Enzo Stock please use our How to Invest in Enzo Biochem guide.
  
Please specify Enzo Biochem's target price for which you would like Enzo Biochem odds to be computed.

Enzo Biochem Target Price Odds to finish below 1.06

The tendency of Enzo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 1.06  after 90 days
 0.73 90 days 1.06 
about 72.45
Based on a normal probability distribution, the odds of Enzo Biochem to stay under $ 1.06  after 90 days from now is about 72.45 (This Enzo Biochem probability density function shows the probability of Enzo Stock to fall within a particular range of prices over 90 days) . Probability of Enzo Biochem price to stay between its current price of $ 0.73  and $ 1.06  at the end of the 90-day period is about 72.21 .
Considering the 90-day investment horizon the stock has the beta coefficient of 1.55 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Enzo Biochem will likely underperform. Additionally Enzo Biochem has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Enzo Biochem Price Density   
       Price  

Predictive Modules for Enzo Biochem

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Enzo Biochem. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.030.705.02
Details
Intrinsic
Valuation
LowRealHigh
0.101.916.23
Details
0 Analysts
Consensus
LowTargetHigh
5.015.506.11
Details

Enzo Biochem Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Enzo Biochem is not an exception. The market had few large corrections towards the Enzo Biochem's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Enzo Biochem, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Enzo Biochem within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.44
β
Beta against Dow Jones1.55
σ
Overall volatility
0.10
Ir
Information ratio -0.1

Enzo Biochem Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Enzo Biochem for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Enzo Biochem can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Enzo Biochem generated a negative expected return over the last 90 days
Enzo Biochem has some characteristics of a very speculative penny stock
Enzo Biochem has high historical volatility and very poor performance
The company reported the last year's revenue of 31.91 M. Reported Net Loss for the year was (26.08 M) with profit before taxes, overhead, and interest of 11.57 M.
Enzo Biochem has about 82.37 M in cash with (26.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.
Roughly 22.0% of the company shares are held by company insiders
On 2nd of December 2024 Enzo Biochem paid $ 0.1 per share dividend to its current shareholders
Latest headline from gurufocus.com: Enzo Biochem Stock Surges 5.19 percent Amid Market Activity

Enzo Biochem Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Enzo Stock often depends not only on the future outlook of the current and potential Enzo Biochem's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enzo Biochem's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding50.9 M
Cash And Short Term Investments52.4 M

Enzo Biochem Technical Analysis

Enzo Biochem's future price can be derived by breaking down and analyzing its technical indicators over time. Enzo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Enzo Biochem. In general, you should focus on analyzing Enzo Stock price patterns and their correlations with different microeconomic environments and drivers.

Enzo Biochem Predictive Forecast Models

Enzo Biochem's time-series forecasting models is one of many Enzo Biochem's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Enzo Biochem's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Enzo Biochem

Checking the ongoing alerts about Enzo Biochem for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Enzo Biochem help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Enzo Biochem generated a negative expected return over the last 90 days
Enzo Biochem has some characteristics of a very speculative penny stock
Enzo Biochem has high historical volatility and very poor performance
The company reported the last year's revenue of 31.91 M. Reported Net Loss for the year was (26.08 M) with profit before taxes, overhead, and interest of 11.57 M.
Enzo Biochem has about 82.37 M in cash with (26.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.
Roughly 22.0% of the company shares are held by company insiders
On 2nd of December 2024 Enzo Biochem paid $ 0.1 per share dividend to its current shareholders
Latest headline from gurufocus.com: Enzo Biochem Stock Surges 5.19 percent Amid Market Activity

Additional Tools for Enzo Stock Analysis

When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.